Ionis Pharmaceuticals has a 35-year track record of perfecting and advancing RNA-targeted drug discovery and...
In late 2022, Arcturus Therapeutics retained The Chase Group to build out additions to the...
The Chase Group is pleased to announce the successful recruitment of Elvis Osei Tutu, PharmD,...
Amid an era of rapid growth, Genmab retained The Chase Group to secure a new...
The Chase Group, committed to executive recruitment in life sciences, is pleased to announce the...
Biologics Consulting, currently experiencing a season of growth, retained The Chase to build out their...
Alexza Pharmaceuticals stands at the crossroads of innovation and advanced technology with a platform that...
The Chase Group (TCG) is pleased to announce the successful recruitment of David Geller, MD...
The Chase Group, known for its thorough search capabilities and expertise in Life Sciences Executive...
Building on a 14+ year relationship with Chase, the Chief Medical Officer of Checkmate Pharmaceuticals...
The Chase Group was once again retained by Akcea Therapeutics to complete an extensive executive...
The Chase Group, known for relationship building with proven success in life sciences executive search,...
Following an extensive search of industry and academic professionals by The Chase Group, the Allen...
After a comprehensive executive search that was filled in less than two months, The Chase...
As a result of their partnership with The Chase Group, Genmab has secured a Director,...
The Chase Group is proud to partner with Eisai and support their human health care...
To support their rapid growth and expanding portfolio of rare disease programs, Aeglea Biotherapeutics retained...
Dr. Suzana Couto joins Genmab Pharmaceuticals as Head of Pathology, leading the pathology teams located...
Through our ongoing partnership, Aeglea Biotherapeutics has secured a Vice President, Clinical Development, Rare Disease....
The Chase Group is pleased to announce our latest placement for Ionis Pharmaceuticals. Due to...
The Chase Group is pleased to announce the successful completion of the Vice President, Global...
The Chase Group is pleased to announce the successful completion of the Director, Clinical Research,...
Dr. Eliel Bayever Joins OncoQuest as Chief Medical Officer. We are so proud to connect...
The Chase Group appreciates and values our continued partnership with Ionis Pharmaceuticals and is pleased...
The Chase Group, Inc. is pleased to announce the successful completion of a search for...
The Chase Group announces another successful leadership recruitment with the placement of the Vice President...
Ionis Pharmaceuticals has retained The Chase Group, Inc. to help build their GCP QA team....
Ipsen Biopharmaceuticals has retained The Chase Group once again to work with their commercial leadership...
The Chase Group recently completed a highly competitive search for the Head of Regulatory Affairs...
The Chase Group is proud to announce the completion of the Chief Medical Officer search...
The Chase Group proudly announces the successful completion of a search for the Chief Medical...
Akcea Therapeutics has retained The Chase Group to secure a Chief Medical Officer to join...